Animal Wound Care Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Product (Surgical Wound Care Products (Sutures And Staplers, Tissue Adhesive, Sealants, And Glues), Advanced Wound Care Products(Foam Dressings, Hydrocolloid Dressings, Film Dressings, Hydrogel Dressings, Other Advanced Dressings), Traditional Wound Care Products(Tapes, Dressings, Bandages, Absorbents, Other Traditional Wound Care Products), Therapy Devices), By Animal (Companion Animal (Cats, Dogs, Horses, Another Companion Animal), Livestock (Cattle, Pigs, Other Livestock Animals), By End user (Hospitals & Clinics, Homecare, and Others), By Region and Competition 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 2.71 Billion
CAGR (2026-2031)	5.75%
Fastest Growing Segment	Companion Animal
Largest Market	North America
Market Size (2031)	USD 3.79 Billion

Market Overview

The Global Animal Wound Care Market will grow from USD 2.71 Billion in 2025 to USD 3.79 Billion by 2031 at a 5.75% CAGR. The Global Animal Wound Care Market comprises medical devices and products, such as sutures, tissue adhesives, and advanced dressings, designed for the treatment of acute and chronic injuries in livestock and companion animals. The primary drivers fueling market growth include the rising rate of pet adoption globally and the increasing willingness of owners to invest in high-quality veterinary healthcare. Furthermore, the growing prevalence of post-operative care requirements and the expansion of veterinary surgical facilities actively support the demand for effective wound management solutions, distinct from emerging technological trends.

However, the market faces a significant challenge regarding the high costs associated with advanced veterinary treatments, which may impede accessibility for cost-sensitive owners. This financial constraint is notable given the substantial capital already flowing into the sector. According to the American Pet Products Association, in 2024, United States expenditures on veterinary care and product sales reached approximately $39.8 billion. While this figure illustrates strong market potential, it also highlights the economic pressure that could limit the widespread adoption of premium wound care products in price-sensitive regions.

Key Market Drivers

The rising adoption of companion animals and the concurrent trend of pet humanization significantly propel the demand for animal wound care products. As owners increasingly view pets as integral family members, the frequency of veterinary visits for treating traumatic injuries and performing elective surgeries rises, directly necessitating the utilization of medical textiles, sutures, and tissue adhesives. This demographic shift is quantifiable in recent industry data. According to FEDIAF EuropeanPetFood, June 2024, in the 'Facts & Figures 2024' report, approximately 91 million households in Europe owned at least one pet. This substantial ownership base creates a sustained baseline demand for veterinary services and associated wound management consumables across the continent.

The growing penetration of pet insurance and reimbursement policies acts as a secondary catalyst by mitigating the financial burden of veterinary procedures on animal owners. With reduced out-of-pocket expenses, veterinary professionals can prescribe optimal treatments, including advanced dressings and regenerative therapies, which might otherwise be declined due to cost constraints. This trend is evidenced by the robust performance of the insurance sector; according to the North American Pet Health Insurance Association, May 2024, in the 'State of the Industry Report 2024', the total premium volume for pet insurance in North America reached $4.27 billion. Furthermore, the magnitude of funding directed toward animal health recovery is expanding globally. According to the Association of British Insurers, in 2024, pet insurers paid out a record £1 billion in claims, highlighting the increasing financial resources supporting veterinary interventions.

Download Free Sample Report

Key Market Challenges

The high cost associated with advanced veterinary treatments serves as a substantial barrier to the expansion of the global animal wound care market. While the industry offers effective products for managing acute and chronic injuries, the financial burden of these treatments often forces livestock producers and pet owners to select less expensive alternatives. This price sensitivity is particularly acute when animals require long-term care or frequent dressing changes, leading to a hesitation in adopting premium medical devices. Consequently, the market experiences restricted penetration in regions where the expense of veterinary services outweighs the perceived value of specialized wound management.

The economic pressure on animal owners directly correlates with the limited uptake of these products. According to the Association of British Insurers, in 2024, the total value of pet insurance claims reached a record 1 billion pounds, a figure driven largely by the escalating costs of veterinary procedures and medication. This rising financial load creates an environment where cost often dictates the course of treatment rather than clinical necessity. As a result, manufacturers face difficulty scaling their operations in cost-conscious segments, which dampens overall market revenue despite the growing need for animal healthcare.

Key Market Trends

The Accelerated Adoption of Regenerative Medicine and Stem Cell Therapies represents a pivotal shift in the market, moving beyond symptomatic management toward curative solutions for chronic animal ailments. This trend is characterized by significant capital inflows into biotechnology firms developing off-the-shelf, species-specific cell therapies for conditions like osteoarthritis and feline chronic gingivostomatitis. Unlike traditional pharmaceuticals, these biological treatments address the root causes of tissue damage, attracting substantial investor confidence and enabling the industrial scaling of advanced therapeutic modalities. For instance, according to Gallant Therapeutics, June 2025, in the 'Gallant Closes $18 Million Series B' press release, the company secured $18 million in funding to commercialize its allogeneic stem cell pipeline, explicitly targeting the mass market distribution of these novel regenerative solutions.

The Emergence of Non-Antibiotic Antimicrobial Wound Management Strategies is fundamentally reshaping product portfolios as regulatory bodies and veterinarians actively combat antimicrobial resistance (AMR). This pressure compels manufacturers to innovate with alternative bioactive materials, such as silver-infused dressings, medical-grade honey, and antimicrobial peptides, which provide infection control without relying on conventional drug classes. This transition is actively creating a therapeutic void that alternative therapies are now filling, as evidenced by the sharp decline in traditional drug usage. According to the Veterinary Medicines Directorate, November 2025, in the 'UK-VARSS 2024' report, sales of veterinary antibiotics for use in food-producing animals reached a historic low of 15.6 mg/kg, signaling a critical market opportunity for non-antibiotic wound care innovations to replace these restricted pharmaceuticals.

Segmental Insights

The companion animal segment is projected to register the fastest growth within the global animal wound care market, primarily driven by rising pet adoption rates and the increasing humanization of pets. This cultural shift encourages owners to invest significantly in veterinary healthcare, resulting in elevated demand for effective wound management products. Additionally, the growing prevalence of chronic diseases and the necessity for post-operative care in aging dogs and cats further stimulate this expansion. Consequently, the continuous improvement in veterinary infrastructure supports the heightened consumption of wound care solutions for companion animals globally.

Regional Insights

North America maintains a leading position in the global animal wound care market due to high pet ownership rates and increased expenditure on veterinary services. This regional dominance is supported by a strong presence of major market players and well-established veterinary healthcare infrastructure. Additionally, the proactive role of the U.S. Food and Drug Administration, specifically the Center for Veterinary Medicine, in regulating and approving animal health products fosters a stable environment for product development. These factors collectively ensure the region remains central to the global industry.

Recent Developments

• In December 2024, Virbac completed the acquisition of Mopsan, a long-standing distribution partner based in Turkey, to strengthen its direct presence in the region's growing animal health market. This strategic transaction allowed the company to integrate a dedicated team and robust logistics network, enhancing the distribution of its portfolio, including companion animal dermatology and wound management products. By transitioning from a distributor model to a direct subsidiary operation, the company aimed to optimize the availability of its solutions for veterinary professionals and improve its responsiveness to local market demands in the wound care and pet health segments.
• In November 2024, Sonoma Pharmaceuticals, Inc. received a new 510(k) clearance from the U.S. Food and Drug Administration for its Microcyn-based hydrogel, expanding its application in animal and human wound care. The regulatory approval covered improved biocompatibility and an extended shelf life for the stabilized hypochlorous acid product. The clearance indicated the hydrogel for managing various skin conditions, including burns, ulcers, and surgical wounds, under the supervision of healthcare professionals. This development allowed the company to market its advanced wound management technology with enhanced claims, further solidifying its portfolio in the global healthcare and veterinary sectors.
• In August 2024, Noxsano, Inc. released favorable results from two clinical studies validating the efficacy of its nitric oxide-releasing wound dressings for veterinary use. The research demonstrated that the company's Restore Wound Pads and Gels significantly reduced healing times for animal wounds compared to standard treatments. The published data highlighted the products' ability to accelerate granulation and wound contraction, validating their utility in managing traumatic injuries and surgical sites. This breakthrough reinforced the company's position in the animal wound care market by offering a cost-effective, scientifically proven solution for accelerating tissue repair in veterinary patients.
• In May 2024, epiq Animal Health and KeraVet Bio announced a strategic partnership to distribute a novel wound management solution for companion animals. The collaboration focused on bringing KeraVet Gel, a keratin-based topical product, to the veterinary market to treat surgical incisions and complex wounds in dogs and cats. This reformulation of an FDA-cleared human product was designed to accelerate tissue healing while incorporating a deterrent to prevent animals from licking the affected area. The agreement appointed epiq Animal Health as the master distributor, aiming to streamline supply chain operations and enhance access to this advanced wound care technology for veterinary clinics.

Key Market Players

• Elanco Animal Health
• Ethicon, Inc.
• Medtronic PLC
• B. Braun Melsungen AG
• Jorgen Kruuse A/S
• Dechra Pharmaceuticals
• Sonoma Pharmaceuticals Inc.
• Neogen Corporation
• Jazz Medical, LLC
• Prima-Vet Inc.

By Product	By Animal	By End user	By Region
Surgical Wound Care Products (Sutures And Staplers, Tissue Adhesive, Sealants, And Glues) Advanced Wound Care Products(Foam Dressings, Hydrocolloid Dressings, Film Dressings, Hydrogel Dressings, Other Advanced Dressings) Traditional Wound Care Products(Tapes, Dressings, Bandages, Absorbents, Other Traditional Wound Care Products) Therapy Devices	Companion Animal (Cats, Dogs, Horses, Another Companion Animal) Livestock (Cattle, Pigs, Other Livestock Animals)	Hospitals & Clinics Homecare and Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Animal Wound Care Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Animal Wound Care Market, By Product:

• Surgical Wound Care Products (Sutures And Staplers, Tissue Adhesive, Sealants, And Glues)
• Advanced Wound Care Products(Foam Dressings, Hydrocolloid Dressings, Film Dressings, Hydrogel Dressings, Other Advanced Dressings)
• Traditional Wound Care Products(Tapes, Dressings, Bandages, Absorbents, Other Traditional Wound Care Products)
• Therapy Devices

• Animal Wound Care Market, By Animal:

• Companion Animal (Cats, Dogs, Horses, Another Companion Animal)
• Livestock (Cattle, Pigs, Other Livestock Animals)

• Animal Wound Care Market, By End user:

• Hospitals & Clinics
• Homecare
• and Others

• Animal Wound Care Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE